series-b
Stage
2014
Founded
1
Investors
About
Vyriad is a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers.
Explore Vyriad's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.